D
Dong-Sheng Huang
Publications - 21
Citations - 277
Dong-Sheng Huang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 9 publications receiving 197 citations.
Papers
More filters
Journal ArticleDOI
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
Dong-Sheng Huang,Zhaohui Wang,Xujun He,Bill H. Diplas,Rui Yang,Patrick J. Killela,Qun Meng,Zai-Yuan Ye,Wei Wang,Xiao-Ting Jiang,Li Xu,Xiang-Lei He,Zhong-Sheng Zhao,Wen-Juan Xu,Hui-Ju Wang,Ying-Yu Ma,Ying-Jie Xia,Li Li,Ru-Xuan Zhang,Tao Jin,Zhong-kuo Zhao,Ji Xu,Sheng Yu,Fang Wu,Junbo Liang,Wang Sizhen,Yuchen Jiao,Hai Yan,Hou-Quan Tao +28 more
TL;DR: TERT promoter mutations are frequent in multiple tumour types and have similar distributions in Chinese cancer patients, making them potential therapeutic targets.
Journal ArticleDOI
Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
Yong Yu,Jingjing Qi,Jieyi Xiong,Liping Jiang,Di Cui,Junlin He,Ping Chen,Lianjie Li,Chenjie Wu,Tonghui Ma,Su Shao,Jianjun Wang,Dansong Yu,Bing Zhou,Dong-Sheng Huang,Clemens A. Schmitt,Clemens A. Schmitt,Ran Tao +17 more
TL;DR: A new avenue for TNBC treatment is opened by targeting the EZH2-H3K27me3-TET1 pathway that can modulate the epigenetic landscape and provide evidence regarding how to exploit it as a novel therapeutic target via its pivotal role in senescence and apoptosis control.
Journal ArticleDOI
HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
Xujun He,Zhengchuang Liu,Ying-Jie Xia,Ji Xu,Guocai Lv,Lu Wang,Tonghui Ma,Liping Jiang,Yiping Mou,Xiao-Ting Jiang,Jie Ma,Zhong-kuo Zhao,Haibin Ni,Wen-Juan Xu,Guo-Qing Ru,Dong-Sheng Huang,Hou-Quan Tao +16 more
TL;DR: The results showed that increased expression of HOXB7 might play an important role in promoting GC proliferation, migration and invasion by inducing both AKT and MAPK pathways, thus resulting in progression of, and poor prognosis in GC patients.
Journal ArticleDOI
Prevalence of deleterious ATM germline mutations in gastric cancer patients.
Dong-Sheng Huang,Hou-Quan Tao,Xujun He,Ming Long,Sheng Yu,Ying-Jie Xia,Zhang Wei,Zikai Xiong,Sian Jones,Yiping He,Hai Yan,Xiaoyue Wang +11 more
TL;DR: This study discovered two germline ATM mutations in a Chinese family with a history of gastric cancer by screening 83 cancer susceptibility genes and found deleterious germline mutations of ATM in 2.7% of 335 Gastric cancer patients of different ethnic origins.
Journal ArticleDOI
CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma
Guo-Qing Ru,Yong Han,Wei Wang,Yuan Chen,Hui-Ju Wang,Wen-Juan Xu,Jie Ma,Mei-Hua Ye,Xi Chen,Xiang-Lei He,Balázs Győrffy,Balázs Győrffy,Zhong-Sheng Zhao,Dong-Sheng Huang +13 more
TL;DR: Data mining results show that CEACAM6 is overexpressed in gastric cancer and is correlated with lymph node metastasis, and data mining discovered that Tamoxifen etc. could be therapeutic alternatives for gastric patients with CEACam6 overexpression.